Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(258)
•••
Post by qwerty22on Aug 31, 2020 10:53am
218 Views
Post# 31479129

Manufacturing delays for VIDO-Intervac

Manufacturing delays for VIDO-Intervachttps://www.cbc.ca/news/canada/saskatoon/vido-intervac-university-of-saskatchewan-manufacturing-delays-canada-vaccine-1.5694008

I guess among the media considered one of the leading homegrown developers. Now has domestic manufacturing issues. Really highlights the limitations of biologic vaccines in their capacity to serve very large numbers. VBIV (and to some extent Medicago) fall into this category. Highlighting IMV's manfacturing simplicity as another developer stumbles on this front looks like a winner.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities